Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
Omeros Corporation (OMER)
Last omeros corporation earnings: 3/2 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.omeros.com
Company Research
Source: Business Wire
– Expands DRI royalty deal on U.S. net sales of OMIDRIA –– Expanded deal brings Omeros $115 million upfront payment and opportunity for additional $55 million in sales-based milestones – SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today announced the sale to DRI Healthcare Acquisitions LP (“DRI”), a wholly owned subsidiary of DRI Healthcare Trust, of an expanded interest in certain royalty payments based on net sales of OMIDRIA in the United States.OMIDRIA, a novel ophthalmic product for use in cataract and lens replacement surgery, was invented and first commercialized by Omeros. In December 2021, Omeros sold OMIDRIA and related business assets to Rayner Surgical Inc. (“Rayner”). Under the terms of that asset purchase agreement, Omeros is entitled to receive royalties on net sales of OMIDRIA. On September 30, 2022, Omeros and DRI entered into a royalty purchase agreement under which Omeros received $125 million in cash in exchange for a portion, subject to annual c
Show less
Read more
Impact Snapshot
Event Time:
OMER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMER alerts
High impacting Omeros Corporation news events
Weekly update
A roundup of the hottest topics
OMER
News
- Omeros Co. (NASDAQ: OMER) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial ResultsBusiness Wire
- Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024Business Wire
OMER
Earnings
- 11/9/23 - Beat
OMER
Sec Filings
- 4/29/24 - Form DEF
- 4/29/24 - Form ARS
- 4/29/24 - Form 4
- OMER's page on the SEC website